EcoDrugPlus

Prostaglandin E Receptor 4

Ensembl ID : ENSLACG00000002507
Gene Symbol: PTGER4
4 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSLACG00000013339
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSLACG00000001325
Gene Symbol: PTGS1
4 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSLACG00000008168
Gene Symbol: PTGS2
4 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSLACG00000012559
Gene Symbol: PSMA1
4 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSLACG00000013454
Gene Symbol: PSMA2
4 Cross references
270 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSLACG00000018893
Gene Symbol: PSMA3
4 Cross references
241 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSLACG00000000790
Gene Symbol: PSMA4
4 Cross references
253 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSLACG00000015948
Gene Symbol: PSMA5
4 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSLACG00000017724
Gene Symbol: PSMA6
4 Cross references
323 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSLACG00000004628
Gene Symbol: PSMA7
3 Cross references
157 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSLACG00000011602
Gene Symbol: PSMA8
4 Cross references
197 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).